{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:29:26Z","timestamp":1792250966729,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06700-w","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:19Z","timestamp":1723719739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["p38\u03b1 deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9147-2115","authenticated-orcid":false,"given":"Tingting","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suidong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-0711","authenticated-orcid":false,"given":"Kinya","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-5478","authenticated-orcid":false,"given":"Gonghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"6700_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerback, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397, 754\u2013766 (2021).","journal-title":"Lancet"},{"key":"6700_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y. & Guo, C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 13, 81 (2022).","journal-title":"Cell Death Dis."},{"key":"6700_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227\u2013255 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"6700_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","volume":"19","author":"T Dainichi","year":"2018","unstructured":"Dainichi, T. et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat. Immunol. 19, 1286\u20131298 (2018).","journal-title":"Nat. Immunol."},{"key":"6700_CR5","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"6700_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651 (2007).","journal-title":"Nature"},{"key":"6700_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"C Albanesi","year":"2018","unstructured":"Albanesi, C., Madonna, S., Gisondi, P. & Girolomoni, G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front. Immunol. 9, 1549 (2018).","journal-title":"Front. Immunol."},{"key":"6700_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mucimm.2023.02.005","volume":"16","author":"A Trompette","year":"2023","unstructured":"Trompette, A. & Ubags, N. D. Skin barrier immunology from early life to adulthood. Mucosal Immunol. 16, 194\u2013207 (2023).","journal-title":"Mucosal Immunol."},{"key":"6700_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564\u2013569 (2007).","journal-title":"Nature"},{"key":"6700_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983\u20131994 (2009).","journal-title":"J. Exp. Med."},{"key":"6700_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J. E., Chan, T. C. & Krueger, J. G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J. Allergy Clin. Immunol. 140, 645\u2013653 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"6700_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","volume":"39","author":"S Morizane","year":"2012","unstructured":"Morizane, S. & Gallo, R. L. Antimicrobial peptides in the pathogenesis of psoriasis. J. Dermatol. 39, 225\u2013230 (2012).","journal-title":"J. Dermatol."},{"key":"6700_CR13","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb, J. E. et al. Psoriasis. Nat. Rev. Dis. Prim. 2, 16082 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"6700_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur, J. S. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679\u2013692 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"6700_CR15","doi-asserted-by":"publisher","first-page":"569751","DOI":"10.1155\/2013\/569751","volume":"2013","author":"A Mavropoulos","year":"2013","unstructured":"Mavropoulos, A., Rigopoulou, E. I., Liaskos, C., Bogdanos, D. P. & Sakkas, L. I. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin. Dev. Immunol. 2013, 569751 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"6700_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","volume":"152","author":"C Johansen","year":"2005","unstructured":"Johansen, C. et al. The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin. Br. J. Dermatol. 152, 37\u201342 (2005).","journal-title":"Br. J. Dermatol."},{"key":"6700_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.yexmp.2007.05.002","volume":"83","author":"XJ Yu","year":"2007","unstructured":"Yu, X. J. et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp. Mol. Pathol. 83, 413\u2013418 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"6700_CR18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1365-2133.2010.09706.x","volume":"162","author":"L Soegaard-Madsen","year":"2010","unstructured":"Soegaard-Madsen, L., Johansen, C., Iversen, L. & Kragballe, K. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br. J. Dermatol 162, 1216\u20131223 (2010).","journal-title":"Br. J. Dermatol"},{"key":"6700_CR19","doi-asserted-by":"publisher","first-page":"eaao1685","DOI":"10.1126\/scisignal.aao1685","volume":"11","author":"T Zheng","year":"2018","unstructured":"Zheng, T. et al. p38alpha signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation. Sci. Signal. 11, eaao1685 (2018).","journal-title":"Sci. Signal."},{"key":"6700_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2018.00569","volume":"9","author":"W Zhao","year":"2018","unstructured":"Zhao, W. et al. MAPK phosphatase-1 deficiency exacerbates the severity of imiquimod-induced psoriasiform skin disease. Front. Immunol. 9, 569 (2018).","journal-title":"Front. Immunol."},{"key":"6700_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/bjd.12020","volume":"168","author":"RB Kjellerup","year":"2013","unstructured":"Kjellerup, R. B., Johansen, C., Kragballe, K. & Iversen, L. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin. Br. J. Dermatol. 168, 339\u2013345 (2013).","journal-title":"Br. J. Dermatol."},{"key":"6700_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2133.2012.10939.x","volume":"167","author":"K Mihara","year":"2012","unstructured":"Mihara, K., Elliott, G. R., Boots, A. M. & Nelissen, R. L. Inhibition of p38 kinase suppresses the development of psoriasis-like lesions in a human skin transplant model of psoriasis. Br. J. Dermatol. 167, 455\u2013457 (2012).","journal-title":"Br. J. Dermatol."},{"key":"6700_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2019.06.019","volume":"144","author":"K Sakurai","year":"2019","unstructured":"Sakurai, K. et al. Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis. J. Allergy Clin. Immunol. 144, 1036\u20131049 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"6700_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3906\/biy-1904-37","volume":"43","author":"C Sumer","year":"2019","unstructured":"Sumer, C., Boz Er, A. B. & Dincer, T. Keratin 14 is a novel interaction partner of keratinocyte differentiation regulator: receptor-interacting protein kinase 4. Turk. J. Biol. 43, 225\u2013234 (2019).","journal-title":"Turk. J. Biol."},{"key":"6700_CR25","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965\u20133976 (2012).","journal-title":"J. Clin. Invest."},{"key":"6700_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13555-021-00677-8","volume":"12","author":"K Sugiura","year":"2022","unstructured":"Sugiura, K. Role of interleukin 36 in generalised pustular psoriasis and beyond. Dermatol. Ther. (Heidelb.) 12, 315\u2013328 (2022).","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"6700_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/jid.2008.294","volume":"129","author":"H Watanabe","year":"2009","unstructured":"Watanabe, H. et al. Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J. Invest. Dermatol. 129, 650\u2013656 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"6700_CR28","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","volume":"190","author":"A Johnston","year":"2013","unstructured":"Johnston, A. et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190, 2252\u20132262 (2013).","journal-title":"J. Immunol."},{"key":"6700_CR29","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","volume":"136","author":"L Senra","year":"2016","unstructured":"Senra, L. et al. Keratinocyte-derived IL-17E contributes to inflammation in psoriasis. J. Invest. Dermatol. 136, 1970\u20131980 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"6700_CR30","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41590-022-01339-3","volume":"23","author":"X Ni","year":"2022","unstructured":"Ni, X. et al. IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. Nat. Immunol. 23, 1577\u20131587 (2022).","journal-title":"Nat. Immunol."},{"key":"6700_CR31","first-page":"182","volume":"17","author":"M Kastelan","year":"2009","unstructured":"Kastelan, M., Prpic-Massari, L. & Brajac, I. Apoptosis in psoriasis. Acta Dermatovenerol. Croat. 17, 182\u2013186 (2009).","journal-title":"Acta Dermatovenerol. Croat."},{"key":"6700_CR32","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1002\/cpim.71","volume":"125","author":"TP Singh","year":"2019","unstructured":"Singh, T. P., Zhang, H. H., Hwang, S. T. & Farber, J. M. IL-23- and imiquimod-induced models of experimental psoriasis in mice. Curr. Protoc. Immunol. 125, e71 (2019).","journal-title":"Curr. Protoc. Immunol."},{"key":"6700_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin, D. A. et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J. Invest. Dermatol. 133, 17\u201326 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"6700_CR34","doi-asserted-by":"publisher","first-page":"111897","DOI":"10.1016\/j.celrep.2022.111897","volume":"41","author":"FP Veras","year":"2022","unstructured":"Veras, F. P. et al. Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation. Cell Rep. 41, 111897 (2022).","journal-title":"Cell Rep."},{"key":"6700_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/odi.14457","volume":"30","author":"S Fukada","year":"2022","unstructured":"Fukada, S. et al. Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes. Oral Dis. 30, 639\u2013649 (2022).","journal-title":"Oral Dis."},{"key":"6700_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14740338.2019.1614561","volume":"18","author":"SS Kolli","year":"2019","unstructured":"Kolli, S. S., Kepley, A. L., Cline, A. & Feldman, S. R. A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data. Expert Opin. Drug Saf. 18, 523\u2013536 (2019).","journal-title":"Expert Opin. Drug Saf."},{"key":"6700_CR37","doi-asserted-by":"publisher","first-page":"15876","DOI":"10.1074\/jbc.M906232199","volume":"275","author":"JE Smolen","year":"2000","unstructured":"Smolen, J. E. et al. L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein kinase. J. Biol. Chem. 275, 15876\u201315884 (2000).","journal-title":"J. Biol. Chem."},{"key":"6700_CR38","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1006\/bbrc.2000.2540","volume":"270","author":"R Tandon","year":"2000","unstructured":"Tandon, R., Sha\u2019afi, R. I. & Thrall, R. S. Neutrophil beta2-integrin upregulation is blocked by a p38 MAP kinase inhibitor. Biochem. Biophys. Res. Commun. 270, 858\u2013862 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6700_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00024382-200205000-00016","volume":"17","author":"W Yan","year":"2002","unstructured":"Yan, W. et al. Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide. Shock 17, 433\u2013438 (2002).","journal-title":"Shock"},{"key":"6700_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2007.03.011","volume":"26","author":"A Hidalgo","year":"2007","unstructured":"Hidalgo, A., Peired, A. J., Wild, M., Vestweber, D. & Frenette, P. S. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26, 477\u2013489 (2007).","journal-title":"Immunity"},{"key":"6700_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni.2258","volume":"13","author":"X Liu","year":"2012","unstructured":"Liu, X. et al. Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat. Immunol. 13, 457\u2013464 (2012).","journal-title":"Nat. Immunol."},{"key":"6700_CR42","doi-asserted-by":"publisher","first-page":"101801","DOI":"10.1016\/j.jbc.2022.101801","volume":"298","author":"O Molinar-Inglis","year":"2022","unstructured":"Molinar-Inglis, O. et al. Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells. J. Biol. Chem. 298, 101801 (2022).","journal-title":"J. Biol. Chem."},{"key":"6700_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/exd.13750","volume":"27","author":"HC Bae","year":"2018","unstructured":"Bae, H. C. et al. RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes. Exp. Dermatol. 27, 1126\u20131133 (2018).","journal-title":"Exp. Dermatol."},{"key":"6700_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.micinf.2014.08.005","volume":"16","author":"L Zhao","year":"2014","unstructured":"Zhao, L., Xia, J., Wang, X. & Xu, F. Transcriptional regulation of CCL20 expression. Microbes Infect. 16, 864\u2013870 (2014).","journal-title":"Microbes Infect."},{"key":"6700_CR45","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/eji.200838852","volume":"39","author":"N Kanda","year":"2009","unstructured":"Kanda, N. et al. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur. J. Immunol. 39, 996\u20131006 (2009).","journal-title":"Eur. J. Immunol."},{"key":"6700_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jdermsci.2017.05.018","volume":"88","author":"H Li","year":"2017","unstructured":"Li, H. et al. Cyr61\/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK\/AP-1 pathway in psoriasis. J. Dermatol. Sci. 88, 46\u201356 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"6700_CR47","doi-asserted-by":"publisher","first-page":"E12313","DOI":"10.1073\/pnas.1814705115","volume":"115","author":"T Zheng","year":"2018","unstructured":"Zheng, T. et al. Protein kinase p38alpha signaling in dendritic cells regulates colon inflammation and tumorigenesis. Proc. Natl Acad. Sci. USA 115, E12313\u2013E12322 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6700_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/cdd.2017.56","volume":"24","author":"K Kanemaru","year":"2017","unstructured":"Kanemaru, K. et al. Phospholipase Cdelta1 regulates p38 MAPK activity and skin barrier integrity. Cell Death Differ. 24, 1079\u20131090 (2017).","journal-title":"Cell Death Differ."},{"key":"6700_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/exd.12187","volume":"22","author":"M Mose","year":"2013","unstructured":"Mose, M., Kang, Z., Raaby, L., Iversen, L. & Johansen, C. TNFalpha- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK. Exp. Dermatol. 22, 476\u2013481 (2013).","journal-title":"Exp. Dermatol."},{"key":"6700_CR50","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jid.2016.04.012","volume":"136","author":"C Johansen","year":"2016","unstructured":"Johansen, C., Bertelsen, T., Ljungberg, C., Mose, M. & Iversen, L. Characterization of TNF-alpha- and IL-17A-mediated synergistic induction of DEFB4 gene expression in human keratinocytes through IkappaBzeta. J. Invest. Dermatol. 136, 1608\u20131616 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"6700_CR51","doi-asserted-by":"publisher","first-page":"111800","DOI":"10.1016\/j.intimp.2024.111800","volume":"130","author":"JH Lee","year":"2024","unstructured":"Lee, J. H. et al. NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation. Int. Immunopharmacol. 130, 111800 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"6700_CR52","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/154405910708600902","volume":"86","author":"JF Schindler","year":"2007","unstructured":"Schindler, J. F., Monahan, J. B. & Smith, W. G. p38 pathway kinases as anti-inflammatory drug targets. J. Dent. Res. 86, 800\u2013811 (2007).","journal-title":"J. Dent. Res."},{"key":"6700_CR53","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/ni.1640","volume":"9","author":"C Kim","year":"2008","unstructured":"Kim, C. et al. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9, 1019\u20131027 (2008).","journal-title":"Nat. Immunol."},{"key":"6700_CR54","doi-asserted-by":"publisher","first-page":"10611","DOI":"10.1128\/MCB.24.24.10611-10620.2004","volume":"24","author":"K Nishida","year":"2004","unstructured":"Nishida, K. et al. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 24, 10611\u201310620 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"6700_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2207","volume":"13","author":"G Huang","year":"2012","unstructured":"Huang, G. et al. Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat. Immunol. 13, 152\u2013161 (2012).","journal-title":"Nat. Immunol."},{"key":"6700_CR56","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00403-015-1587-6","volume":"307","author":"S Huang","year":"2015","unstructured":"Huang, S. et al. Involvement of epithelial Wntless in the regulation of postnatal hair follicle morphogenesis. Arch. Dermatol. Res. 307, 835\u2013839 (2015).","journal-title":"Arch. Dermatol. Res."},{"key":"6700_CR57","doi-asserted-by":"publisher","first-page":"101052","DOI":"10.1016\/j.xpro.2021.101052","volume":"3","author":"K Sakamoto","year":"2022","unstructured":"Sakamoto, K., Goel, S., Funakoshi, A., Honda, T. & Nagao, K. Flow cytometry analysis of the subpopulations of mouse keratinocytes and skin immune cells. STAR Protoc. 3, 101052 (2022).","journal-title":"STAR Protoc."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06700-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T12:16:02Z","timestamp":1723724162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06700-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6700"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06700-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"999"}}